RafaelJesusFernandezIIIMDPhD
Pulmonology • Nashville, TNCritical Care Medicine, Interstitial Lung Diseases
Fellow
Dr. Fernandez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Vanderbilt University Medical Center
Nashville, TN 37232
Education & Training
Vanderbilt University Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2024 - 2028- Vanderbilt University Medical CenterResidency, Internal Medicine, 2022 - 2024
- Vanderbilt University Medical CenterInternship, Internal Medicine, 2022 - 2023
Perelman School of Medicine at the University of PennsylvaniaClass of 2022, MD-PhD
Yale UniversityBS, Molecular Biophysics and Biochemistry, 2009 - 2013
Certifications & Licensure
TN State Medical License 2024 - 2025
Publications & Presentations
PubMed
- Patient-Induced Pluripotent Stem Cell-Derived Hepatostellate Organoids Establish a Basis for Liver Pathologies in Telomeropathies.Young-Jun Choi, Melissa S Kim, Joshua H Rhoades, Nicolette M Johnson, Corbett T Berry
Cellular and Molecular Gastroenterology and Hepatology. 2023-01-01 - 11 citationsGSK3 inhibition rescues growth and telomere dysfunction in dyskeratosis congenita iPSC-derived type II alveolar epithelial cells.Rafael Jesus Fernandez, Zachary J G Gardner, Katherine J Slovik, Derek C Liberti, Katrina N Estep
Elife. 2022-05-13 - 10 citationsA regulatory loop connecting WNT signaling and telomere capping: possible therapeutic implications for dyskeratosis congenita.Rafael Fernandez, F. Brad Johnson
Annals of the New York Academy of Sciences. 2018-04-01
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
